Parkinson's Disease iPS Cell Line Research Consortium

Overview

About this study

This study is being done to collect skin samples from people with and without neurodegenerative and vascular disorders including Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), stroke and many others. We will use these skin samples to make and bank (store) a group of cells (cell line) called inducible pluripotent stem (iPS) cells.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Willing and able to give informed consent
Male and females over the age of 18
Diagnosis of Parkinson's Disease (PD), other neurodegenerative conditions, and vascular disorders with genetic mutation or family members if needed to maintain blinded status to their mutation.
Patients with Parkinson's Disease (PD), other neurodegenerative disorders, and vascular disorders who do not have known family history.
Age/gender controls

Exclusion Criteria:

Patients that do not want to participate by either checking no on the contact letter or refusing over the phone. This will be recorded in the progeny system and patients will not be contacted again.
Allergy to study-related materials including lidocaine or iodine

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Zbigniew Wszolek, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Audrey Strongosky C.C.R.C. (904)953-6096 Strongosky.Audrey2@mayo.edu
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Mark Pittelkow, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Mark Pittelkow M.D. (480)301-8508 pittelkow.mark@mayo.edu

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Zbigniew Wszolek, M.D.

Closed-enrolling by invitation

Contact information:

Audrey Strongosky C.C.R.C.

(904)953-6096

Strongosky.Audrey2@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mark Pittelkow, M.D.

Closed-enrolling by invitation

Contact information:

Mark Pittelkow M.D.

(480)301-8508

pittelkow.mark@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials